ElastiMed Welcomes Dr. Amir Belson as a Member of the Board of Directors

ElastiMed has appointed Dr. Amir Belson to its Board of Directors.

Rhea-AI Summary

ElastiMed has appointed Dr. Amir Belson to its Board of Directors. Dr. Belson brings extensive experience in the medical device industry, having founded several successful companies including Neoguide Systems (acquired by Intuitive Surgical), Vascular Pathways (acquired by C.R. Bard), and Zipline Medical (acquired by Stryker). The appointment comes as ElastiMed prepares to bring its innovative compression therapy device to market. The company focuses on developing wearable medical devices for lymphatic and venous disease patients.

Positive

• Strategic appointment of experienced medical device industry leader with successful M&A track record
• Company is advancing towards market launch phase of its compression therapy device
• Leadership addition comes at important commercialization stage

Negative

• None.

Argus Session date unavailable

-4.12% session move Open Argus

Details

News Market Reaction – TRNLY

The recorded move for TRNLY in the trading session of this news was -4.12%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

YOKNEAM, Israel, Oct. 28, 2024 /PRNewswire/ -- ElastiMed Ltd. a leading innovator in wearable medical devices, is proud to announce the appointment of Dr. Amir Belson as a member of its Board of Directors.

Dr. Belson is a prominent figure in the medical device industry with extensive experience guiding healthcare companies from early development to commercialization and successful M&A transactions. He founded Neoguide Systems (robotic endoscopy), acquired by Intuitive Surgical in 2009; Vascular Pathways (vascular intervention), acquired by C.R. Bard in 2014; and Zipline Medical (wound closure), acquired by Stryker in 2019. Dr. Belson has also founded other innovative companies, including Venocare, Radiaction Medical, Emboline, Follisave and Modular Surgical.

"I am honored to join ElastiMed as a member of the Board," said Dr. Belson. "ElastiMed is by far the most innovative company in the compression therapy arena. Their wearable medical devices will bring relief to tens of millions of lymphatic and venous disease sufferers around the world and empower them to lead the life they wish rather than being limited by their conditions. I am excited to work with the talented team to drive additional innovation and create impactful solutions for patients and healthcare providers."

Dr. Belson's appointment comes at a pivotal time for ElastiMed as the company is embarking on a quest to bring their device to market. With his proven track record of leadership and entrepreneurship, Dr. Belson will play a key role in guiding ElastiMed through its next phase of growth and development.

"We are thrilled to welcome Dr. Belson to ElastiMed's Board," said Mr. Omer Zelka, Founder & CEO of ElastiMed. "Amir's expertise will be instrumental as we continue to advance our mission of revolutionizing care at home for lymphedema and venous disease patients through wearable technology. Dr. Belson is widely recognized for his contributions to the medical device industry. His commitment to improving patients' outcomes and enhancing healthcare delivery aligns perfectly with ElastiMed's core values."

About Elastimed:

ElastiMed's wearable medical devices are designed to treat and manage lymphatic and venous diseases. With a focus on innovation, ElastiMed designs cutting-edge solutions empowering patients and healthcare providers alike. ElastiMed is dedicated to improving patients' outcomes, addressing health equity challenges and enhancing healthcare delivery at home.

ElastiMed is a portfolio company of The Trendlines Group Ltd. (SGX: 42T) (OTCQX: TRNLY), and has received funding from the Israeli Innovation Authority, Horizon 2020, and private investors.

For more information about Elastimed and its innovative products, please visit www.elastimed.com

Contact:
Omer Zelka
omer@elastimed.com

Photo: https://mma.prnewswire.com/media/2541681/Amir_Belson_Board_Member_ElastiMed.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/elastimed-welcomes-dr-amir-belson-as-a-member-of-the-board-of-directors-302288527.html

SOURCE ElastiMed Ltd.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who is Dr. Amir Belson and what companies has he founded?

Dr. Amir Belson is a medical device industry expert who founded Neoguide Systems (acquired by Intuitive Surgical in 2009), Vascular Pathways (acquired by C.R. Bard in 2014), Zipline Medical (acquired by Stryker in 2019), and other companies including Venocare, Radiaction Medical, Emboline, Follisave and Modular Surgical.

What is ElastiMed's main product focus?

ElastiMed focuses on developing wearable medical devices for compression therapy, specifically targeting lymphatic and venous disease patients.

What is the strategic timing of Dr. Belson's appointment to ElastiMed?

Dr. Belson's appointment comes at a pivotal time as ElastiMed is preparing to bring their compression therapy device to market and enter their next phase of growth and development.